Danaher Co. (NYSE:DHR) Shares Purchased by Hemenway Trust Co LLC

Hemenway Trust Co LLC increased its holdings in Danaher Co. (NYSE:DHR) by 0.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 156,379 shares of the conglomerate’s stock after purchasing an additional 1,438 shares during the period. Danaher makes up 3.4% of Hemenway Trust Co LLC’s portfolio, making the stock its 8th biggest position. Hemenway Trust Co LLC’s holdings in Danaher were worth $43,477,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Savvy Advisors Inc. increased its holdings in shares of Danaher by 402.8% during the third quarter. Savvy Advisors Inc. now owns 4,349 shares of the conglomerate’s stock worth $1,209,000 after buying an additional 3,484 shares in the last quarter. Ashton Thomas Private Wealth LLC increased its holdings in shares of Danaher by 1.3% during the third quarter. Ashton Thomas Private Wealth LLC now owns 5,365 shares of the conglomerate’s stock worth $1,492,000 after buying an additional 68 shares in the last quarter. Verus Capital Partners LLC acquired a new stake in shares of Danaher during the third quarter worth approximately $203,000. WealthPlan Investment Management LLC increased its holdings in shares of Danaher by 28.4% during the third quarter. WealthPlan Investment Management LLC now owns 26,436 shares of the conglomerate’s stock worth $7,350,000 after buying an additional 5,842 shares in the last quarter. Finally, Harbour Investments Inc. increased its holdings in shares of Danaher by 3.0% during the third quarter. Harbour Investments Inc. now owns 1,531 shares of the conglomerate’s stock worth $426,000 after buying an additional 45 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DHR. Stephens reaffirmed an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Leerink Partners raised their price target on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Stifel Nicolaus raised their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. StockNews.com raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Finally, Barclays lowered their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by company insiders.

Danaher Stock Up 0.1 %

Shares of NYSE:DHR traded up $0.22 during midday trading on Tuesday, reaching $243.47. 184,724 shares of the company were exchanged, compared to its average volume of 2,735,135. Danaher Co. has a fifty-two week low of $193.75 and a fifty-two week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $264.37 and a two-hundred day simple moving average of $260.82. The firm has a market cap of $175.85 billion, a PE ratio of 46.42, a P/E/G ratio of 4.51 and a beta of 0.85.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 EPS. As a group, sell-side analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.